Non-pharmacological treatment options of drug-resistant epilepsy in subcortical band heterotopia: systematic review and illustrative case

被引:6
作者
Kurzbuch, Arthur R. [1 ]
Cooper, Ben [1 ]
Israni, Anil [2 ]
Ellenbogen, Jonathan R. [1 ]
机构
[1] Alder Hey Childrens NHS Fdn Trust, Dept Neurosurg, Liverpool, Merseyside, England
[2] Alder Hey Childrens NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England
关键词
Subcortical band heterotopia; Double cortex; Subcortical laminar heterotopia; Epilepsy; Seizure; Treatment; DOUBLE CORTEX SYNDROME; MULTIPLE SUBPIAL TRANSECTION; CORPUS CALLOSOTOMY; INTRACTABLE EPILEPSY; CORTICAL DYSPLASIA; SURGICAL RESECTION; MALFORMATIONS; SEIZURES;
D O I
10.1007/s00381-022-05638-w
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective Subcortical band heterotopia is a rare X-linked neuronal migration disorder primarily in females often associated with drug-resistant epilepsy. The aim of this study is to review the literature for non-pharmacological treatment options of drug-resistant epilepsy in subcortical band heterotopia. Material and methods In accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, we performed a systematic review. Entering the keywords "double cortex," "subcortical band heterotopia," and "subcortical laminar heterotopia," we searched Scopus and PubMed databases. We paid particular attention to type of invasive and non-invasive treatment, radiological presentation, and outcome. We also describe a related case report, managed at Alder Hey Children's Hospital, Liverpool. Results The systematic literature review yielded 25 patients with subcortical band heterotopia and drug-resistant epilepsy who underwent non-pharmacological treatment. Including our patient, 26 patients were reported. The patients' mean age at seizure onset was 6.5 years (range 0.2-23) with a female sex predilection (5.25:1). The patients' mean age at invasive or non-invasive treatment was 21.5 years (range 6.5-51). The 26 patients underwent 29 non-pharmacological treatments. Ten patients underwent corpus callosotomy; 8 patients had a formal temporal lobectomy. Three patients had focal cortical resection. Two patients respectively had multiple subpial transections, insertion of a vagal nerve stimulator, or deep brain stimulation of the bilateral anterior nuclei of the thalamus. One patient underwent responsive focal neurostimulation. Another patient had transcutaneous stimulation of the vagal nerve. Sixteen patients reported a reduction or the disappearance of the seizures; 1 patient had no improvement. The outcome of 2 patients was classified class I, of 1 patient class II, of 1 patient class III, and of 5 patients class IV according to the Engel Epilepsy Surgery Outcome Scale. Conclusion Mainly corpus callosotomy and formal temporal lobectomy have been performed as non-pharmacological treatment with few cases published overall. Several other invasive procedures and one non-invasive technique are based on case reports. The small number of reported cases prevents drawing a firm conclusion as to which non-pharmacological treatment is the best treatment option for refractive epilepsy in patients with subcortical band heterotopia.
引用
收藏
页码:451 / 462
页数:12
相关论文
共 50 条
[21]   Non-pharmacological treatment of gambling disorder: a systematic review of randomized controlled trials [J].
Ribeiro, Eliana O. ;
Afonso, Nuno H. ;
Morgado, Pedro .
BMC PSYCHIATRY, 2021, 21 (01)
[22]   Non-pharmacological interventions for the treatment of erectile dysfunction in adult men: systematic review [J].
Hernando-Berrios, Macarena ;
Soledad Rivera-Martinez, Maria ;
Gualda-Vergara, Veronica .
ENFERMERIA CLINICA, 2008, 18 (02) :64-69
[23]   Deciphering the surgical treatment gap for drug-resistant epilepsy (DRE): A literature review [J].
Solli, Elena ;
Colwell, Nicole A. ;
Say, Irene ;
Houston, Rebecca ;
Johal, Anmol S. ;
Pak, Jayoung ;
Tomycz, Luke .
EPILEPSIA, 2020, 61 (07) :1352-1364
[24]   Non-pharmacological interventions for the treatment of post-stroke fatigue: A systematic review [J].
Komber, Ahmad ;
Chu, Shuk Han ;
Zhao, Xu ;
Komber, Hend ;
Halbesma, Nynke ;
Mead, Gillian .
INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (06) :611-621
[25]   Social Work and Non-Pharmacological Treatment on Iranian Children with Hemophilia: A Systematic Review [J].
Nasiri, Mona ;
Khalvati, Maliheh ;
Ostadhashemi, Leila ;
Khalvati, Monireh ;
Khalvati, Mahboube ;
Mamashli, Khadijeh ;
Babakhanian, Masaudeh ;
Ghazanfarpour, Masumeh ;
Mirzaee, Firoozeh ;
Salajeheh, Zahra .
INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD, 2020, 8 (02) :10827-10835
[26]   Non-pharmacological treatment of gambling disorder: a systematic review of randomized controlled trials [J].
Eliana O. Ribeiro ;
Nuno H. Afonso ;
Pedro Morgado .
BMC Psychiatry, 21
[27]   Focal drug-resistant temporal lobe epilepsy associated with an ipsilateral anterior choroidal artery aneurysm: illustrative case [J].
Phillips, H. Westley ;
Rangwala, Shivani D. ;
Papadakis, Joanna ;
Segar, David J. ;
Tsuboyama, Melissa ;
Pinto, Anna L. R. ;
Harmon, Joseph P. ;
Soriano, Sulpicio G. ;
Munoz, Carlos J. ;
Madsen, Joseph R. ;
See, Alfred P. ;
Stone, Scellig S. .
JOURNAL OF NEUROSURGERY-CASE LESSONS, 2023, 5 (26)
[28]   Advances and guidance in the treatment of drug-resistant epilepsy: a review by the Andalusian Epilepsy Society of the new drugs cenobamate, fenfluramine and cannabidiol [J].
Arenas-Cabrera, Carmen ;
Cabezudo-Garcia, Pablo ;
Calvo-Medina, Rocio ;
Galeano-Bilbao, Benito ;
Martinez-Agredano, Paula ;
Ruiz-Gimenez, Jesus ;
Rodriguez-Uranga, Juan J. ;
Quiroga-Subirana, Pablo .
REVISTA DE NEUROLOGIA, 2024, 79 (06) :161-173
[29]   RELN gene-related drug-resistant epilepsy with periventricular nodular heterotopia treated with radiofrequency thermocoagulation: a case report [J].
Li, Zijian ;
Wang, Fuli ;
He, Zhidong ;
Guo, Qi ;
Zhang, Jinnan ;
Liu, Songyan .
FRONTIERS IN NEUROLOGY, 2024, 15
[30]   Long-term efficacy and adverse effects of cannabidiol in adjuvant treatment of drug-resistant epilepsy: a systematic review and meta-analysis [J].
Liu, Shengyi ;
He, Zihua ;
Li, Jinmei .
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2023, 16